2025
SJR Q3
JCR Q4 · 1,3
OA
ESCI
Journal detail
Journal of Stem Cells and Regenerative Medicine
- Publisher
- M/S GN Corporation Co. Ltd
- Country
- Japan · Asiatic Region
- Type
- journal
- ISSN
-
09737154
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,334
- Quartile Q3
- H-Index 21
- Cites/doc 1
- Docs (3y) 26
- Cites (3y) 31
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,3
- 5Y JIF 2,3
- JCI 0,28
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Biochemistry Q4
- Biotechnology Q3
- Cell Biology Q4
- Molecular Biology Q4
Areas
- Biochemistry, Genetics and Molecular Biology
WoS categories
- Cell & Tissue Engineering
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,334 | 1,3 | 2,3 | 0,28 | Q4 | 21 |
| 2024 | Q3 | Q4 | 0,411 | 1,6 | 2 | 0,34 | Q4 | 19 |
| 2023 | Q3 | Q4 | 0,331 | 1,1 | 1,2 | 0,36 | Q4 | 19 |
| 2022 | Q3 | — | 0,382 | 2,7 | 1,9 | 0,36 | Q4 | 19 |
| 2021 | Q4 | — | 0,219 | — | — | 0,21 | Q4 | 19 |
| 2020 | Q3 | — | 0,346 | — | — | 0,23 | Q4 | 19 |
| 2019 | Q3 | — | 0,431 | — | — | — | — | 19 |
| 2017 | Q3 | — | 0,369 | — | — | — | — | 19 |
| 2016 | Q3 | — | 0,431 | — | — | — | — | 19 |
| 2015 | Q3 | — | 0,354 | — | — | — | — | 19 |
| 2014 | Q3 | — | 0,253 | — | — | — | — | 19 |
| 2013 | Q3 | — | 0,223 | — | — | — | — | 19 |
| 2012 | Q3 | — | 0,217 | — | — | — | — | 19 |
| 2011 | Q4 | — | 0,141 | — | — | — | — | 19 |
| 2010 | — | — | — | — | — | — | — | 19 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL & TISSUE ENGINEERING | ESCI | Q4 | Q4 | 31/32 |
| 2024 | CELL & TISSUE ENGINEERING | ESCI | Q4 | Q4 | 31/32 |
| 2023 | CELL & TISSUE ENGINEERING | ESCI | Q4 | Q4 | 30/31 |
| 2022 | CELL & TISSUE ENGINEERING | ESCI | — | Q4 | — |
| 2021 | CELL & TISSUE ENGINEERING | ESCI | — | Q4 | — |
| 2020 | CELL & TISSUE ENGINEERING | ESCI | — | Q4 | — |